Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
642 In a multicenter, randomized, double-blind, placebo-controlled phase-3 clinical trial conducted in China, acetyllevocarnitine hydrochloride treatment for 24 weeks significantly improved symptoms and somatosensory symptoms in patients with DPN, with a treatment effect of 65% higher than placebo
Scientific Reports, 12 (1), 1-9
Reputable IV therapy providers in Los Angeles are transparent about pricing and outline costs upfront
With this product the pen is a practical product format for the laboratory context and changes nothing about the molecule itself
these drugs will become more available, not less
US$ 28.66
US$ 22.00
US$ 25.45
